Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing Research

Frontiers in Psychiatry

Marc L. Steinberg¹  Billie Bonevski²  David J. Castle³  Sandra Bucci⁵  Sharon Lawn⁶  Ann McNeill⁷  Debbie Robson⁸  Amanda L. Baker⁹ 

[1] Public Health, Flinders UniversityAdelaide, SA, Australia;Department of Psychiatry, St Vincent's Hospital MelbourneFitzroy, VIC, Australia;Department of Psychiatry, University of MelbourneMelbourne, VIC, Australia;Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical SchoolNew Brunswick, NJ, United States;Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science CentreUniversity of Manchester, Manchester, United Kingdom;;Flinders Human Behaviour and Health Research Unit, Department of Psychiatry, Margaret Tobin Centre, College of Medicine &Greater Manchester Mental Health NHS Foundation TrustManchester, United Kingdom;Institute of Psychiatry, Psychology and NeuroscienceKing's College London, London, United Kingdom;School of Medicine and Public Health, University of NewcastleNewcastle, NSW, Australia;

关键词: smoking;    smoking cessation;    schizophrenia;    research;    health priorities;    severe mental illness;   

DOI  :  10.3389/fpsyt.2018.00711

来源: DOAJ

【 摘 要 】

Although tobacco smoking is very common among people with schizophrenia and has devastating effects on health, strategies to ameliorate the risk are lacking. Some studies have reported promising results yet quit rates are much lower than in the general population. There is a need to advance research into smoking cessation efforts among people with schizophrenia. We posed the following question to five leading international experts in the field: “What are the top three research ideas we need to prioritize in order to advance the field of reducing smoking amongst people with schizophrenia?” They identified three broad priorities: (i) deeper understanding about the relationship between smoking, smoking cessation and symptomatology; (ii) targeted, adaptive and responsive behavioral interventions evaluated with smarter methodologies; and (iii) improvements in delivery of interventions. Efforts should be made to establish a collaborative international research agenda.

【 授权许可】

Unknown